A detailed history of Canada Pension Plan Investment Board transactions in Abb Vie Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 2,868,905 shares of ABBV stock, worth $584 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
2,868,905
Previous 2,339,198 22.64%
Holding current value
$584 Million
Previous $426 Million 15.52%
% of portfolio
0.51%
Previous 0.46%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $82 Million - $95.7 Million
529,707 Added 22.64%
2,868,905 $492 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $6.74 Million - $7.68 Million
-42,165 Reduced 1.77%
2,339,198 $426 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $14.2 Million - $16 Million
103,100 Added 4.53%
2,381,363 $369 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $49 Million - $56.7 Million
366,500 Added 19.17%
2,278,263 $340 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $11.3 Million - $14.1 Million
85,500 Added 4.68%
1,911,763 $258 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $3.95 Million - $4.55 Million
-27,343 Reduced 1.48%
1,826,263 $291 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $52.6 Million - $63.1 Million
-380,216 Reduced 17.02%
1,853,606 $300 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $53.3 Million - $61.2 Million
-397,490 Reduced 15.11%
2,233,822 $300 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $42.9 Million - $54.5 Million
-311,548 Reduced 10.59%
2,631,312 $403 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $51.1 Million - $63.4 Million
-386,916 Reduced 11.62%
2,942,860 $477 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $55 Million - $69.6 Million
511,735 Added 18.16%
3,329,776 $451 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $99.8 Million - $113 Million
-938,366 Reduced 24.98%
2,818,041 $304 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $71.9 Million - $80.1 Million
683,374 Added 22.24%
3,756,407 $423 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $234 Million - $258 Million
2,287,225 Added 291.07%
3,073,033 $333 Million
Q4 2020

Feb 17, 2021

SELL
$80.49 - $108.67 $19.5 Million - $26.3 Million
-242,291 Reduced 23.57%
785,808 $84.2 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $130 Million - $153 Million
-1,512,909 Reduced 59.54%
1,028,099 $90.1 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $104 Million - $140 Million
1,422,244 Added 127.13%
2,541,008 $249 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $46.9 Million - $71.1 Million
727,151 Added 185.68%
1,118,764 $85.2 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $86.5 Million - $108 Million
-1,199,124 Reduced 75.38%
391,613 $34.7 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $104 Million - $125 Million
-1,644,569 Reduced 50.83%
1,590,737 $120 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $982,477 - $1.26 Million
-14,954 Reduced 0.46%
3,235,306 $235 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $228 Million - $269 Million
2,960,315 Added 1020.99%
3,250,260 $262 Million
Q4 2018

Feb 06, 2019

SELL
$77.85 - $96.01 $177 Million - $218 Million
-2,272,900 Reduced 88.69%
289,945 $26.7 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $46.3 Million - $51.5 Million
-521,000 Reduced 16.89%
2,562,845 $242 Million
Q2 2018

Aug 07, 2018

SELL
$89.78 - $106.23 $109 Million - $129 Million
-1,212,954 Reduced 28.23%
3,083,845 $286 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $90.2 Million - $121 Million
980,600 Added 29.57%
4,296,799 $407 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $54.3 Million - $59.5 Million
606,139 Added 22.37%
3,316,199 $321 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $38.4 Million - $49 Million
549,200 Added 25.42%
2,710,060 $241 Million
Q2 2017

Jan 31, 2018

SELL
N/A
-991,130 Reduced 31.44%
2,160,860 $157 Million
Q1 2017

Jan 31, 2018

BUY
N/A
3,151,990
3,151,990 $205 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.